This inflammatory response is thought to result in the degradation of the intestinal villi and epithelial lining of the small intestine, which results in an overall inability to absorb nutrients, accounting for the symptoms associated with Celiac disease
Zhang D, Tong X, VanDommelen K, Gupta N, Stamper K, Brady GF, Meng Z, Lin J, Rui L, Omary MB, Yin L (2017) Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity
Mercks pembrolizumab (Keytuda) was first approved in 2014 and has become a $30B/year behemoth and the best-selling drug
Form: Serum
BPC-157 is a synthetic peptide commonly discussed in wellness-focused programs involving recovery support, mobility wellness, muscle support, and wellness-focused healing care
GLP-1 and Foot Health: Key Benefits &